Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · PAR

Par Drugs & Chemicals Ltd

HealthcarePharmaceuticals & Biotechnology₹139 cr market cap
₹114.95 ▲ +1.4% today As of 19 Nov 2026
52-week low ₹78.5852-week high ₹168.25

-32.6% from the 52-week high · +44.3% above the low

Par Drugs & Chemicals Ltd. engages in the development and manufacture of Active Pharma Ingredients (API) for the domestic market as well as for exports to international markets. The company is headquartered in Bhavnagar, Gujarat. The company went IPO on 2019-05-16. The firm also produces a range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide and sucralfate USP. The firm owns and operates its manufacturing facilities at Bhavnagar in Gujarat. The company has over four manufacturing blocks at Bhavnagar, which are for different products having a capacity of approximately 9,700 metric tons per annum.

The short version. Promoter holding was 73.41% in Sep 2026, up 0.04 points over 8 quarters.

1 · The price

How has the stock traded?

Par Drugs & Chemicals Ltd trades 32.6% below its 52-week high and 44.3% above its 52-week low.

Change over period: —

1M+7.2%
3M+12.4%
6M+33.5%
1Y+20.5%

4 · The owners

Who holds it, and are they adding?

Promoter holding73.41%

Up 0.04 pts over 8 quarters.

Domestic institutions0.09%

Up 0.09 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter73.3773.3773.3773.3773.4173.4173.4173.41+0.04
FII000000000
DII0000000.090.09+0.09
Public26.6326.6326.6326.6326.5926.5926.5126.51-0.12

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for Par Drugs & Chemicals Ltd are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about Par Drugs & Chemicals Ltd

What is the Par Drugs & Chemicals Ltd share price?

Par Drugs & Chemicals Ltd (PAR) last closed at ₹114.95, up 1.4% on the day. Its 52-week range is ₹78.58 to ₹168.25.

What is the market cap of Par Drugs & Chemicals Ltd?

Par Drugs & Chemicals Ltd has a market capitalisation of about ₹139 crore. Its price-to-earnings ratio is 10.7.

How are Par Drugs & Chemicals Ltd's latest results?

Promoter holding was 73.41% in Sep 2026, up 0.04 points over 8 quarters.

Who owns Par Drugs & Chemicals Ltd?

As of Sep 2026, shareholding was: Promoter 73.41%, DII 0.09%, Public 26.51%.

How many mutual funds hold Par Drugs & Chemicals Ltd?

0 mutual fund schemes held Par Drugs & Chemicals Ltd in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 22 Nov 2021 · Interim Dividend - Rs. 1.25
  • 27 Apr 2021 · Bonus issue 1:1

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.